A potentially breathable, respiratory vaccine in development has been shown to provide long-term protection for non-human primates against the deadly Ebola virus, as reported this week in the online edition of the journal Molecular Pharmaceutics.
George Georgiou, a professor at The University of Texas at Austin whose technology developments in the engineering, medical, biochemical and cellular fields could help treat tens of thousands of patients with diseases such as cancer and osteoporosis, has been elected as a member of the Institute of Medicine (IOM).
A team of graduate students from the McCombs School of Business and the College of Natural Sciences won top prize last month at the Wake Forest University Biotechnology Conference and Case Competition.
University of Texas at Austin College of Pharmacy Professor Named American Institute for Medical and Biological Engineering Fellow
Dr. Robert O. (Bill) Williams III, professor of pharmaceutics in The University of Texas at Austin College of Pharmacy, has been elected to the college of fellows of the American Institute for Medical and Biological Engineering (AIMBE).